EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep

Robert Galinsky iD, Simerdeep K Dhillon, Sharmony B Kelly, Guido Wassink, Joanne O Davidson iD, Christopher A Lear iD, Lotte G van den Heuij, Laura Bennet iD, Alistair J Gunn iD

The Journal of Physiology · 2023

DOI: 10.1113/jp284381 ↗

At a glance

Journal article in The Journal of Physiology, 2023. Written by Robert Galinsky and 8 co-authors. Institution: Department of Physiology, University of Auckland, Auckland, New Zealand. Major MEDLINE topics: Premature Birth, White Matter. Cited 16 times so far (Crossref); 87 references. The full text is freely available (open access, CC BY 4.0). Funded by: Health Research Council of New Zealand, Auckland Medical Research Foundation, National Health and Medical Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Maternal magnesium sulphate (MgSO 4 ) treatment is widely recommended before preterm birth for neuroprotection. However, this is controversial because there is limited evidence that MgSO 4 provides long‐term neuroprotection. Preterm fetal sheep (104 days gestation; term is 147 days) were assigned randomly to receive sham occlusion with saline infusion ( n = 6) or i.v. infusion with MgSO 4 ( n = 7) or vehicle (saline, n = 6) from 24 h before hypoxia–ischaemia induced by umbilical cord occlusion until 24 h after occlusion. Sheep were killed after 21 days of recovery, for fetal brain histology. Functionally, MgSO 4 did not improve long‐term EEG recovery. Histologically, in the premotor cortex and striatum, MgSO 4 infusion attenuated post‐occlusion astrocytosis (GFAP + ) and microgliosis but did not affect numbers of amoeboid microglia or improve neuronal survival. In the periventricular and intragyral white matter, MgSO 4 was associated with fewer total (Olig‐2 + ) oligodendrocytes compared with vehicle + occlusion. Numbers of mature (CC1 + ) oligodendrocytes were reduced to a similar extent in both occlusion groups compared with sham occlusion. In contrast, MgSO 4 was associated with an intermediate improvement in myelin density in the intragyral and periventricular white matter tracts. In conclusion, a clinically comparable dose of MgSO 4 was associated with moderate improvements in white and grey matter gliosis and myelin density but did not improve EEG maturation or neuronal or oligodendrocyte survival. image Key points Magnesium sulphate is widely recommended before preterm birth for neuroprotection; however, there is limited evidence that magnesium sulphate provides long‐term neuroprotection. In preterm fetal sheep exposed to hypoxia–ischaemia (HI), MgSO 4 was associated with attenuated astrocytosis and microgliosis in the premotor cortex and striatum but did not improve neuronal survival after recovery to term‐equivalent age, 21 days after HI. Magnesium sulphate was associated with loss of total oligodendrocytes in the periventricular and intragyral white matter tracts, whereas mature, myelinating oligodendrocytes were reduced to a similar extent in both occlusion groups. In the same regions, MgSO 4 was associated with an intermediate improvement in myelin density. Functionally, MgSO 4 did not improve long‐term recovery of EEG power, frequency or sleep stage cycling. A clinically comparable dose of MgSO 4 was associated with moderate improvements in white and grey matter gliosis and myelin density but did not improve EEG maturation or neuronal or oligodendrocyte survival.

Subjects

MeSH terms (MEDLINE)

Premature BirthWhite MatterInfant, NewbornHumansFemaleSheepAnimalsGray MatterAsphyxiaMagnesium SulfateGliosisCell SurvivalElectroencephalographyIschemiaHypoxia

Author keywords

asphyxiabrainmagnesium sulphateneuroprotectionpreterm birth

Substances

Magnesium Sulfate

Authors and institutions

  • Department of Physiology, University of Auckland, Auckland, New Zealand.
  • The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, Monash University, Victoria, Australia.

ORCID profiles: Robert Galinsky, Joanne O Davidson, Christopher A Lear, Laura Bennet, Alistair J Gunn

Funding

  • Health Research Council of New Zealand
  • Auckland Medical Research Foundation
  • National Health and Medical Research Council

Cite

APA

Galinsky, R., Dhillon, S. K., Kelly, S. B., Wassink, G., Davidson, J. O., Lear, C. A., van den Heuij, L. G., Bennet, L., & Gunn, A. J. (2023). Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep. The Journal of Physiology. https://doi.org/10.1113/jp284381

Vancouver

Galinsky R, Dhillon SK, Kelly SB, Wassink G, Davidson JO, Lear CA, et al. Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep. The Journal of Physiology. 2023. doi:10.1113/jp284381

BibTeX
@article{Galinsky2023,
  author = {Galinsky, Robert and Dhillon, Simerdeep K and Kelly, Sharmony B and Wassink, Guido and Davidson, Joanne O and Lear, Christopher A and van den Heuij, Lotte G and Bennet, Laura and Gunn, Alistair J},
  title = {Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep},
  journal = {The Journal of Physiology},
  year = {2023},
  doi = {10.1113/jp284381}
}
Start for free →